Showing results (681-690 of 863) with videos related to
Sort By:
Pageof 87
O&G Open|March 2, 2026
The Case for Standardized Maternal Cardiac Arrest Simulation Training in Prehospital and Hospital-Based SettingsAndrea D Shields, Jacqueline Vidosh, Thomas W Trimarco, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2002
A multicentre, randomised phase III trial comparing protracted venous infusion (PVI) 5-fluorouracil (5-FU) with PVI 5-FU plus mitomycin C in patients with inoperable oesophago-gastric cancerN C Tebbutt, A Norman, D Cunningham, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 14, 2011
A dose escalation study of gemcitabine plus oxaliplatin in combination with imatinib for gemcitabine-refractory advanced pancreatic adenocarcinomaN Starling, E A Hawkes, I Chau, et al.Bone Marrow Transplantation|September 11, 1998
The importance of CD34+/CD33- cells in platelet engraftment after intensive therapy for cancer patients given peripheral blood stem cell rescueB C Millar, J L Millar, V Shepherd, et al.British Journal of Cancer|May 1, 1996
High-dose chemotherapy and autologous bone marrow transplant in relapsed Hodgkin's disease--a pragmatic prognostic indexM E O'Brien, S Milan, D Cunningham, et al.Clinical Chemistry|August 1, 1978
High-performance liquid-chromatographic separation and fluorescence measurement of biogenic amines in plasma, urine, and tissueT P Davis, C W Gehrke, C W Gehrke, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancerP Ross, M Nicolson, D Cunningham, et al.European Journal of Cancer (Oxford, England : 1990)|November 1, 1995
'Tomudex' (ZD1694): results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia. The 'Tomudex' Colorectal Cancer Study GroupD Cunningham, J R Zalcberg, U Rath, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 14, 2008
Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority studyM L Rothenberg, J V Cox, C Butts, et al.Bone Marrow Transplantation|October 6, 1997
Outcome assessment of a population-based group of 195 unselected myeloma patients under 70 years of age offered intensive treatmentR Powles, N Raje, S Milan, et al.Pageof 87